Follow up info from poster.
"I did ask as I was also aware of a Q1 expectation. Kris informed me that it is 100% dependent on Dr. Voskuhl and her intentions of publication. IMO, I see Riley as a zealous individual and see Kris (being in IR) as one who takes a more cautious approach. With that being said, Q1 still falls within 1H of 2015, but if Voskuhl wants to publish prior to a public PR, we can expect by Q2. As an outsider looking in, I would suspect a partnership deal immediately subsequent to release of positive MRI / cognitive data. This gives SYN more leverage and also de-risks for the potential partner. Most big pharmas are willing to pay more for less risk. I expect big things to happen between May and July. I have plays lined up with some major catalysts in March, April, May and June, so it'll get quite interesting for me. I may be forced to maintain at least a core in SYN after April."
My take...Interesting and possible. Take it for what it is worth.. Something from the internet.
Seel, maybe you have a thought or two on these 2 quotes. Thanks
SYN
Market Data 
Markets 
AI
